These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9879720)

  • 1. Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists.
    Kathmann M; Schlicker E; Marr I; Werthwein S; Stark H; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):623-7. PubMed ID: 9879720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?
    Schlicker E; Kathmann M; Bitschnau H; Marr I; Reidemeister S; Stark H; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):482-8. PubMed ID: 8740140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.
    Schlicker E; Kathmann M; Reidemeister S; Stark H; Schunack W
    Br J Pharmacol; 1994 Aug; 112(4):1043-8. PubMed ID: 7952862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iodoproxyfan, a potent and selective histamine H3 receptor antagonist, on alpha 2 and 5-HT3 receptors.
    Schlicker E; Pertz H; Bitschnau H; Purand K; Kathmann M; Elz S; Schunack W
    Inflamm Res; 1995 Jul; 44(7):296-300. PubMed ID: 8564527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex.
    Schlicker E; Behling A; Lümmen G; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):489-93. PubMed ID: 1352385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
    Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.
    Łazewska D; Kieć-Kononowicz K; Pertz HH; Stark H; Schunack W; Elz S
    Pharmazie; 2001 Dec; 56(12):927-32. PubMed ID: 11802653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model.
    Kathmann M; Schlicker E; Detzner M; Timmerman H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):498-503. PubMed ID: 8114949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
    Cardell LO; Edvinsson L
    Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors.
    Fink K; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):113-7. PubMed ID: 8170496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
    Liedtke S; Flau K; Kathmann M; Schlicker E; Stark H; Meier G; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):43-50. PubMed ID: 12616340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
    Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
    J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
    J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.
    Stark H; Sadek B; Krause M; Hüls A; Ligneau X; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
    J Med Chem; 2000 Oct; 43(21):3987-94. PubMed ID: 11052804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel histamine H(3)-receptor antagonists and partial agonists with a non-aminergic structure.
    Nickel T; Bauer U; Schlicker E; Kathmann M; Göthert M; Sasse A; Stark H; Schunack W
    Br J Pharmacol; 2001 Apr; 132(8):1665-72. PubMed ID: 11309237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors.
    Schlicker E; Fink K; Hinterthaner M; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):633-8. PubMed ID: 2615855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B; Elz S; Pertz HH; Stark H; Schunack W
    Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.
    Schlicker E; Marr I
    Neuroscience; 1997 Jul; 79(1):247-54. PubMed ID: 9178880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex.
    Fink K; Schlicker E; Neise A; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):513-9. PubMed ID: 1965326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.